Resources with keywords: vaccines
This project is supported by McGill University Interdisciplinary Initiative in Infection and Immunity (MI4). The COVID19 Vaccine Tracker is designed to provide clear, accessible, and comprehensive updates about COVID19 vaccine development and approvals worldwide. It includes links to phase 1, phase 2, phase 3 clinical trials.
Updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines
The U.K. is one of the first governments to set out provisional plans for booster shots. It isconcerned that possible further Covid-19 outbreaks over the winter could coincide with awave of influenza and put pressure on the country’s health system
Table including the status of COVID-19 Vaccines within WHO EUL/PQ evaluation process
This information aims to help people with certain medical conditions (weakened immune systems, Bell’s Palsy history, GBS history) make an informed decision about receiving a COVID-19 vaccine.
Answers to help address common myths and rumors.
The Delta strain is now a variant of concern, with indications it is more infectious than other strains.
The greater decline in COVID-19 morbidity and mortality in older adults, the age group with the highest vaccination rates, demonstrates the potential impact of increasing population-level vaccination coverage.
